Figure 4From: Effects of pravastatin, phytosterols, and combination therapy on lipid profile in HIV-infected patients: an open-labelled, randomized cross-over studyComparison of LDL-c reduction between combination therapy and monotherapy. Pravastatin pravastatin, monotherapy in Groups 1 and 2; combination 1, combination therapy in Groups 1 and 2; phytosterols, phytosterols monotherapy in Groups 3 and 4; combination 2 combination therapy in Groups 3 and 4.Back to article page